JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265550

Human WWC2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

WWC2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1.

View Alternative Names

BH-3-only member B, BH3 only member B protein, BOMB, Protein WWC2, WW and C2 domain containing 2, WW domain-containing protein 2, WWC2_HUMAN

1 Images
Sanger Sequencing - Human WWC2 knockout HeLa cell line (AB265550)
  • Sanger seq

Unknown

Sanger Sequencing - Human WWC2 knockout HeLa cell line (AB265550)

Homozygous : 1 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265550-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265550 Human WWC2 knockout HeLa cell line", "number":"AB265550-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265550-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265550 Human WWC2 knockout HeLa cell line", "number":"AB265550-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
WWC2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

WWC2 also known as WW and C2 domain-containing protein 2 is a protein with a mass of approximately 135 kDa. It functions mechanically through its WW and C2 domains that are important for protein-protein interactions. This protein is significantly expressed in various human tissues including the brain liver and heart indicating its broad role in human physiology. Through its structure WWC2 interacts with other cellular proteins potentially influencing multiple pathways.
Biological function summary

WWC2 participates in the regulation of cellular signaling and cell polarity. It is not isolated in its functioning; instead it forms complexes with other proteins such as the aPKC and LATS kinases to exert its biological effects. These interactions suggest its contribution to the Hippo signaling pathway affecting cell growth apoptosis and stem cell functions.

Pathways

WWC2 plays an important role in the Hippo pathway and possibly in cell polarity signaling. In the Hippo pathway WWC2 associates with key components such as LATS1/2 which regulates important cellular processes like proliferation and organ size. Through these interactions WWC2 influences downstream effectors such as YAP/TAZ connecting it to broader cellular outcomes. Additionally its role in cell polarity is suggested by potential interactions with aPKC indicating a role in maintaining cellular structure and function.

Mutations or dysregulation of WWC2 have associations with cancer and neurological disorders. In cancer alterations in the Hippo pathway components including WWC2 can lead to uncontrolled cell growth. While studying its role in neurological disorders scientists note its influence on neuronal cell polarity and signaling. This brings WWC2 into focus alongside proteins like YAP and TAZ which have links to various cancer types and developmental disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com